Paeds SAQs · adolescent-and-young-adult-medicine
Polycystic ovary syndrome in adolescents — formative SAQs
Two formative short-answer questions on adolescent PCOS diagnosis with developmental modification, mimic exclusion, lifestyle-first management and metabolic screening.
On this page & tools
Target exams
SAQ 1 — Diagnostic approach to suspected PCOS (10 marks)
A 16-year-old presents with irregular periods (cycles 40–60 days), moderate acne, and a Ferriman-Gallwey score of 8. Menarche was at age 12. Her mother has type 2 diabetes. A pelvic ultrasound reports "polycystic ovaries." The GP has told the family she has PCOS. [2] [4]
Questions
- State the Rotterdam diagnostic criteria and explain why adolescent-specific modification is required. (4 marks) [4] [2]
- List the investigations needed to confirm the diagnosis and exclude mimics, with one sentence of justification for each. (4 marks) [3] [1]
- Explain whether the ultrasound finding alone establishes the diagnosis in this adolescent. (2 marks) [2] [1]
Model answer
Rotterdam criteria and adolescent modification (4). Rotterdam requires two of three: oligo-/anovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound, after exclusion of mimics. Adolescent modification: do not diagnose on ultrasound alone because multifollicular ovaries are physiologically normal in teens; require persistence of ovulatory dysfunction beyond two years post-menarche and objective hyperandrogenism before applying the label. This patient is four years post-menarche, so persistence is met. [4] [2]
Investigations (4). Total and calculated free testosterone or free androgen index to document biochemical hyperandrogenism (SHBG is suppressed by insulin, so free testosterone is more sensitive than total). TSH to exclude thyroid dysfunction as a cause of menstrual irregularity. Prolactin to exclude hyperprolactinaemia. 17-hydroxyprogesterone to exclude non-classic congenital adrenal hyperplasia — the most important mimic. Fasting glucose or HbA1c and a lipid panel for metabolic screening; consider OGTT if BMI is elevated. [3] [1]
Ultrasound alone (2). The ultrasound finding does not establish the diagnosis. Up to 30–40% of healthy adolescent ovaries meet adult PCOM criteria. The Pena 2025 adolescent recommendations and Rosenfield 2015 statement both caution against ultrasound-based diagnosis in this age group. The diagnosis requires persistent menstrual dysfunction and objective hyperandrogenism, both of which this patient may have, but the ultrasound is supportive rather than diagnostic. [2] [1]
You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References8Show ledgerHide ledger
- [1]Peña AS, Witchel SF, Boivin J, et al. International evidence-based recommendations for polycystic ovary syndrome in adolescents. BMC medicine, 2025.PMID 40069730
- [2]Rosenfield RL The Diagnosis of Polycystic Ovary Syndrome in Adolescents. Pediatrics, 2015.PMID 26598450
- [3]Legro RS Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. Journal of clinical endocrinology and metabolism, 2013.PMID 24151290
- [4]Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and sterility, 2004.PMID 14711538
- [5]Moran LJ Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: Lifestyle management. Obesity reviews, 2020.PMID 32452622
- [6]Hoeger K The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. Journal of clinical endocrinology and metabolism, 2008.PMID 18728175
- [7]Barry JA Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Human reproduction, 2011.PMID 21725075
- [8]Dokras A Screening women with polycystic ovary syndrome for metabolic syndrome. Obstetrics and gynecology, 2005.PMID 15994628